NCT02417844View on ClinicalTrials.gov

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Prostatic Hyperplasia
Interventions
DRUG

tamsulosin (Astellas)

DRUG

Tamsulosin HCL

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY